HUTCHMED (China) Limited - ADR Live Stock Price Today, Share Analysis and Chart

Name: HUTCHMED (China) Limited - ADR: Is Infosys Ltd. worth buying?
Item: HUTCHMED (China) Limited - ADR
Rating: 1.44433325
Author: Trendlyne DVM scores

about

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several...

15.08 -0.10 (-0.66%)

31.13% Gain from 52W Low

16,634

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

9.8 / 100

Technically Neutral

47.9 / 100

1Yr Price target upside is 49%

15 analysts

HUTCHMED China ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

HUTCHMED (China) Limited - ADR Live Stock Price Today, Share Analysis and Chart

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several...

31.13% Gain from 52W Low

SWOT Analysis

HUTCHMED China ADR Live Price Chart